Grupo Zendal | Prensa

El Grupo Zendal

Zendal Portugal

Biofarmacéuticos

Ediciones anteriores

NOTICIA

24 · 02 · 2026

ZENDAL holds an internal scientific session in O Porriño with the participation of Luis Blanco from CSIC

Contacto de prensa

24 · 02 · 2026ZENDAL holds an internal scientific session in O Porriño with the participation of Luis Blanco from CSIC

19 · 02 · 2026Biofabri Appoints Rolando Pajón to Strengthen the Late-Stage Development of Its Tuberculosis Vaccine Candidate

14 · 11 · 2025The Zendal Group presents its Human and Animal Health Awards in a ceremony marking its sixth edition

06 · 11 · 2025Research on aggressive triple-negative breast cancer earns CINBIO (University of Vigo) the Zendal Award in Human Health.

30 · 07 · 2025Leading scientific experts join the jury of the VI International Zendal Awards

05 · 06 · 2025The Sixth Edition of the International Zendal Awards is Now Open for Applications

18 · 03 · 2025ZENDAL receives EMA recommendation for its vaccine against EHD

27 · 02 · 2025Biofabri and IAVI announce first vaccinations in the IMAGINE clinical trial, a large-scale safety and efficacy trial of the tuberculosis vaccine candidate MTBVAC

21 · 01 · 2025Zendal supplied 42 million doses of bluetongue vaccine in Europe during 2024.

12 · 11 · 2024The Zendal Group Honors Human and Animal Health Innovators at its Fifth Annual Awards Gala

24 · 10 · 2024Early detection of Alzheimer’s disease and the development of vaccines against ticks in cattle are the objectives of the projects that won the Zendal Prize.

05 · 07 · 2024Zendal launches first vaccine against Epizootic Haemorrhagic Disease (EHD) in Spain

1
2
3
4